Posner Christopher - Insider Non-Derivative Transactions at Cara Therapeutics, Inc. (CARA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 28, 2025, Posner Christopher's relationship to Cara Therapeutics, Inc. (CARA) is Director,Officer (PRESIDENT AND CEO), and currently has 13,109 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CARA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Posner Christopher - Insider Non-Derivative Transactions of CARA Common Stock

Posner Christopher - Insider Non-Derivative Transactions at CARA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Mar 1, 2025	Sell -- (Common Stock)	583	4.75	13109
Feb 5, 2025	Sell -- (Common Stock)	372	4.72	13692
Nov 5, 2024	Sell -- (Common Stock)	3668	0.29	168768
Aug 2, 2024	Sell -- (Common Stock)	4149	0.35	172436
May 3, 2024	Sell -- (Common Stock)	3936	0.75	176585
Mar 1, 2024	Sell -- (Common Stock)	5834	0.89	180521
Feb 9, 2024	Sell -- (Common Stock)	35575	0.53	186355
Feb 2, 2024	Sell -- (Common Stock)	4981	0.55	221930
Feb 2, 2024	Acquisition -- (Common Stock)	62500	0	226911
Nov 3, 2023	Sell -- (Common Stock)	3796	1.22	164411
Aug 4, 2023	Sell -- (Common Stock)	4307	3.07	168207
May 6, 2023	Sell -- (Common Stock)	3869	4.4	172514
Mar 4, 2023	Sell -- (Common Stock)	5987	9.71	176383
Feb 3, 2023	Sell -- (Common Stock)	4191	11.8	182370